[go: up one dir, main page]

NO20013385L - S-nitrosotioler som midler for behandling av sirkulatoriske dysfunksjoner - Google Patents

S-nitrosotioler som midler for behandling av sirkulatoriske dysfunksjoner

Info

Publication number
NO20013385L
NO20013385L NO20013385A NO20013385A NO20013385L NO 20013385 L NO20013385 L NO 20013385L NO 20013385 A NO20013385 A NO 20013385A NO 20013385 A NO20013385 A NO 20013385A NO 20013385 L NO20013385 L NO 20013385L
Authority
NO
Norway
Prior art keywords
nitrosothiols
agents
treatment
dysfunctions
circulatory
Prior art date
Application number
NO20013385A
Other languages
English (en)
Other versions
NO326806B1 (no
NO20013385D0 (no
Inventor
Jose Repolles Moliner
Eduardo Salas Perez-Rasilla
Francisco Pubill Coy
Juan-Antonio Cerda Riudavets
Christina Negrie Rofes
Lydia Cabeza Llorente
Alicia Ferrer Siso
Nuria Trias Adroher
Marcelli Carbo Banus
Jesus Murat Moreno
Pedro Michelena Llaguno
Original Assignee
Lacer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacer Sa filed Critical Lacer Sa
Publication of NO20013385D0 publication Critical patent/NO20013385D0/no
Publication of NO20013385L publication Critical patent/NO20013385L/no
Publication of NO326806B1 publication Critical patent/NO326806B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO20013385A 1999-01-27 2001-07-06 S-nitrosotioler som midler for behandling av sirkulatoriske dysfunksjoner NO326806B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009900159A ES2147162B1 (es) 1999-01-27 1999-01-27 "s-nitrosotioles como agentes para el tratamiento de disfunciones circulatorias".
PCT/ES2000/000019 WO2000044714A1 (es) 1999-01-27 2000-01-19 S-nitrosotioles como agentes para el tratamiento de disfunciones circulatorias

Publications (3)

Publication Number Publication Date
NO20013385D0 NO20013385D0 (no) 2001-07-06
NO20013385L true NO20013385L (no) 2001-09-17
NO326806B1 NO326806B1 (no) 2009-02-16

Family

ID=8307080

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013385A NO326806B1 (no) 1999-01-27 2001-07-06 S-nitrosotioler som midler for behandling av sirkulatoriske dysfunksjoner

Country Status (37)

Country Link
US (1) US6800612B2 (no)
EP (1) EP1157987B1 (no)
JP (1) JP3795330B2 (no)
KR (1) KR100671878B1 (no)
CN (1) CN1166631C (no)
AP (1) AP1439A (no)
AT (1) ATE249428T1 (no)
AU (1) AU764725B2 (no)
BG (1) BG64983B1 (no)
BR (1) BR0007395B1 (no)
CA (1) CA2359027C (no)
CU (1) CU23098A3 (no)
CZ (1) CZ298871B6 (no)
DE (2) DE60005154T2 (no)
DK (1) DK1157987T3 (no)
EA (1) EA003577B1 (no)
EE (1) EE04524B1 (no)
ES (2) ES2147162B1 (no)
GB (1) GB2363604B (no)
GE (1) GEP20043220B (no)
HK (1) HK1043586A1 (no)
HR (1) HRP20010562B1 (no)
HU (1) HUP0105203A3 (no)
ID (1) ID29777A (no)
IL (1) IL144381A (no)
IS (1) IS2153B (no)
MX (1) MXPA01007570A (no)
NO (1) NO326806B1 (no)
NZ (1) NZ513162A (no)
OA (1) OA11823A (no)
PL (1) PL202372B1 (no)
PT (1) PT1157987E (no)
RS (1) RS50072B (no)
SI (1) SI1157987T1 (no)
TR (1) TR200102003T2 (no)
WO (1) WO2000044714A1 (no)
ZA (1) ZA200106182B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2173044B1 (es) * 2001-03-13 2004-01-16 Lacer Sa Derivados de glicina, n-(n-l-gamma-glutamil-3-(nitrosotio)-l-valil) y sus aplicaciones.
WO2005030135A2 (en) * 2003-09-26 2005-04-07 Nitromed, Inc. Nitrosated glutamic acid compounds, compositions and methods of use
EP1939179A1 (en) * 2006-12-28 2008-07-02 Lacer, S.A. Stable S-nitrosothiols, method of synthesis and use
ES2383846T3 (es) 2007-10-17 2012-06-26 Pharmagenix Ag Composición farmacéutica que comprende S-nitrosoglutatión y un polisacárido

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US37839A (en) * 1863-03-03 Improved spoke-machine
GB1567561A (en) 1977-01-18 1980-05-14 Ucb Sa Amino-spiro(oxa-(orthia)cycloalkane-penam) - carboxylic acids
GB2052497B (en) 1979-06-25 1983-06-29 Ucb Sa 6 - amino - spiro - (penam - 2,4' - piperidine) - 3 - carboxylic acid derivatives
DE3805965A1 (de) 1988-02-25 1989-09-07 Tamas Geb Szenasi Eszter Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe
US5025001A (en) 1988-06-15 1991-06-18 Brigham And Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
EP0412699B1 (en) * 1989-08-07 1994-04-27 Takeda Chemical Industries, Ltd. Nitrosothiol derivatives, their production and use
EP0480060B1 (en) 1990-04-26 1996-10-23 Senju Pharmaceutical Co., Ltd. S-(lower fatty acid)-substituted glutathione derivative
US5187305A (en) * 1990-11-26 1993-02-16 Glaxo Inc. S-nitroso-N-alkonoylpenicillamines
DE69231666T2 (de) 1991-11-14 2001-05-10 Brigham And Women's Hospital, Boston Die nitrosylierung von enzym-sh gruppen als eine therapeutische massnahme
AU662434B2 (en) 1992-08-07 1995-08-31 Sankyo Company Limited Peptides capable of inhibiting the activity of HIV protease, their preparation and their use
AU698748B2 (en) * 1993-09-17 1998-11-05 Brigham And Women's Hospital Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
US5728705A (en) 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
EP0726768B1 (en) 1993-11-02 2000-05-17 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, Department of Health and Human Services Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury
GB9423868D0 (en) 1994-11-25 1995-01-11 Wellcome Found Compounds for use in medicine
US6627738B2 (en) 1995-09-15 2003-09-30 Duke University No-modified hemoglobins and uses therefor
US6489290B2 (en) 1997-03-27 2002-12-03 Trustees Of Boston University Antiplatelet agent

Also Published As

Publication number Publication date
CA2359027C (en) 2008-10-28
BR0007395A (pt) 2001-10-30
JP3795330B2 (ja) 2006-07-12
AU3046000A (en) 2000-08-18
NZ513162A (en) 2003-01-31
AP2001002247A0 (en) 2001-09-30
DE60005154D1 (de) 2003-10-16
ES2147162B1 (es) 2001-03-16
DK1157987T3 (da) 2003-11-24
JP2002535385A (ja) 2002-10-22
EE200100389A (et) 2002-12-16
IS6020A (is) 2001-07-23
CZ20012678A3 (cs) 2001-10-17
GB2363604A (en) 2002-01-02
BG64983B1 (bg) 2006-11-30
MXPA01007570A (es) 2003-05-14
KR100671878B1 (ko) 2007-01-19
AU764725B2 (en) 2003-08-28
CA2359027A1 (en) 2000-08-03
AP1439A (en) 2005-06-27
PL202372B1 (pl) 2009-06-30
EP1157987B1 (en) 2003-09-10
OA11823A (en) 2005-08-16
TR200102003T2 (tr) 2001-12-21
HUP0105203A2 (en) 2002-06-29
PL349006A1 (en) 2002-06-17
HUP0105203A3 (en) 2002-08-28
YU53601A (sh) 2004-03-12
IS2153B (is) 2006-10-13
NO326806B1 (no) 2009-02-16
CN1337946A (zh) 2002-02-27
EP1157987A1 (en) 2001-11-28
HRP20010562B1 (en) 2010-08-31
GEP20043220B (en) 2004-04-26
BG105824A (en) 2002-06-28
US20020058629A1 (en) 2002-05-16
EA200100823A1 (ru) 2002-02-28
BR0007395B1 (pt) 2010-11-16
WO2000044714A1 (es) 2000-08-03
KR20010101767A (ko) 2001-11-14
GB2363604B (en) 2003-09-10
ID29777A (id) 2001-10-11
ES2206178T3 (es) 2004-05-16
DE10083902T1 (de) 2002-01-10
EA003577B1 (ru) 2003-06-26
US6800612B2 (en) 2004-10-05
PT1157987E (pt) 2004-01-30
ZA200106182B (en) 2002-10-28
HRP20010562A2 (en) 2002-08-31
NO20013385D0 (no) 2001-07-06
CU23098A3 (es) 2005-11-18
HK1043586A1 (en) 2002-09-20
SI1157987T1 (en) 2004-02-29
DE60005154T2 (de) 2004-07-08
RS50072B (sr) 2009-01-22
ATE249428T1 (de) 2003-09-15
CN1166631C (zh) 2004-09-15
EE04524B1 (et) 2005-08-15
CZ298871B6 (cs) 2008-02-27
GB0120581D0 (en) 2001-10-17
IL144381A0 (en) 2002-05-23
ES2147162A1 (es) 2000-08-16
IL144381A (en) 2005-08-31

Similar Documents

Publication Publication Date Title
NO20021474L (no) Forbindelser for behandling av ischemi
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
FI20000863A0 (fi) Uusi hoitomenetelmä
DE60020327D1 (de) Wasserbehandlungsvorrichtung
PT1235831E (pt) Novos compostos de oxabispidina uteis no tratamento de arritmias cardiacas
NO20022087L (no) Fremgangsmåte for behandling av diabetes
NO20022692D0 (no) Terapeutiske midler
NO20015288D0 (no) Anvendelse av makrolide forbindelser for behandling av tört öye
DE69918171D1 (de) Wäschebehandlung
DE60220297D1 (de) Wäschebehandlungsmittel
NO20013337L (no) Ny behandling
NO20013385D0 (no) S-nitrosotioler som midler for behandling av sirkulatoriske dysfunksjoner
NO20021718D0 (no) Substituerte pyrroler som antiproliferative midler for behandling av kreft
ATE290060T1 (de) Wäschebehandlung
NO20016301D0 (no) Terapeutiske midler
ID25845A (id) Pengaktif pemutihan berbentuk granul
PT1192156E (pt) Novos compostos de bispidina uteis no tratamento de arritmias cardiacas
SE9903421D0 (sv) Behandlingsförfarande
NO995276D0 (no) Behandlingsbenk

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees